{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:59:03Z","timestamp":1790499543051,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12977-015-0185-1","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T10:42:08Z","timestamp":1435660928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells"],"prefix":"10.1186","volume":"12","author":[{"given":"Yuetsu","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Tomoyose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab A","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"key":"185_CR1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.149.2.735","volume":"149","author":"LJ Zhou","year":"1992","unstructured":"Zhou LJ, Schwarting R, Smith HM, Tedder TF (1992) A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149:735\u2013742","journal-title":"J Immunol"},{"key":"185_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20040741","volume":"385","author":"W Cao","year":"2005","unstructured":"Cao W, Lee SH, Lu J (2005) CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem J 385:85\u201393","journal-title":"Biochem J"},{"key":"185_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00430-003-0179-9","volume":"192","author":"M Wolenski","year":"2003","unstructured":"Wolenski M, Cramer SO, Ehrlich S, Steeg C, Grossschupff G, Tenner-Racz K et al (2003) Expression of CD83 in the murine immune system. Med Microbiol Immunol 192:189\u2013192","journal-title":"Med Microbiol Immunol"},{"key":"185_CR4","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.4049\/jimmunol.179.7.4550","volume":"179","author":"CM Prazma","year":"2007","unstructured":"Prazma CM, Yazawa N, Fujimoto Y, Fujimoto M, Tedder TF (2007) CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo. J Immunol 179:4550\u20134562","journal-title":"J Immunol"},{"key":"185_CR5","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.180.9.5890","volume":"180","author":"S Reinwald","year":"2008","unstructured":"Reinwald S, Wiethe C, Westendorf AM, Breloer M, Probst-Kepper M, Fleischer B et al (2008) CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J Immunol 180:5890\u20135897","journal-title":"J Immunol"},{"key":"185_CR6","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1182\/blood.V96.12.3958","volume":"96","author":"S Yamashiro","year":"2000","unstructured":"Yamashiro S, Wang JM, Yang D, Gong WH, Kamohara H, Yoshimura T (2000) Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood 96:3958\u20133963","journal-title":"Blood"},{"key":"185_CR7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.20050128","volume":"202","author":"RB Mailliard","year":"2005","unstructured":"Mailliard RB, Alber SM, Shen H, Watkins SC, Kirkwood JM, Herberman RB et al (2005) IL-18-induced CD83+ CCR7+ NK helper cells. J Exp Med 202:941\u2013953","journal-title":"J Exp Med"},{"key":"185_CR8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(02)00673-6","volume":"108","author":"Y Fujimoto","year":"2002","unstructured":"Fujimoto Y, Tu L, Miller AS, Bock C, Fujimoto M, Doyle C et al (2002) CD83 expression influences CD4+ T cell development in the thymus. Cell 108:755\u2013767","journal-title":"Cell"},{"key":"185_CR9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/intimm\/13.7.959","volume":"13","author":"BD Hock","year":"2001","unstructured":"Hock BD, Kato M, McKenzie JL, Hart DN (2001) A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int Immunol 13:959\u2013967","journal-title":"Int Immunol"},{"key":"185_CR10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/eji.200636535","volume":"37","author":"C Aerts-Toegaert","year":"2007","unstructured":"Aerts-Toegaert C, Heirman C, Tuyaerts S, Corthals J, Aerts JL, Bonehill A et al (2007) CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol 37:686\u2013695","journal-title":"Eur J Immunol"},{"key":"185_CR11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.194.12.1813","volume":"194","author":"M Lechmann","year":"2001","unstructured":"Lechmann M, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG et al (2001) The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 194:1813\u20131821","journal-title":"J Exp Med"},{"key":"185_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellimm.2014.08.003","volume":"292","author":"H Lin","year":"2014","unstructured":"Lin H, Liang S, Zhong Z, Wen J, Li W, Wang L et al (2014) Soluble CD83 inhibits human monocyte differentiation into dendritic cells in vitro. Cell Immunol 292:25\u201331","journal-title":"Cell Immunol"},{"key":"185_CR13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.leukres.2009.01.001","volume":"33","author":"BD Hock","year":"2009","unstructured":"Hock BD, Fernyhough LJ, Gough SM, Steinkasserer A, Cox AG, McKenzie JL (2009) Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia. Leuk Res 33:1089\u20131095","journal-title":"Leuk Res"},{"key":"185_CR14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.imbio.2014.08.005","volume":"220","author":"S Kreiser","year":"2015","unstructured":"Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C et al (2015) Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology 220:270\u2013279","journal-title":"Immunobiology"},{"key":"185_CR15","doi-asserted-by":"crossref","first-page":"18778","DOI":"10.1073\/pnas.1018994108","volume":"108","author":"L Chen","year":"2011","unstructured":"Chen L, Zhu Y, Zhang G, Gao C, Zhong W, Zhang X (2011) CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2. Proc Natl Acad Sci USA 108:18778\u201318783","journal-title":"Proc Natl Acad Sci USA"},{"key":"185_CR16","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78:6476\u20136480","journal-title":"Proc Natl Acad Sci USA"},{"key":"185_CR17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407\u2013410","journal-title":"Lancet"},{"key":"185_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.410210203","volume":"21","author":"M Osame","year":"1987","unstructured":"Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H et al (1987) Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 21:117\u2013122","journal-title":"Ann Neurol"},{"key":"185_CR19","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","volume":"15","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka K, Tamura K (2014) Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol 15:e517\u2013e526","journal-title":"Lancet Oncol"},{"key":"185_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2183\/pjab.86.117","volume":"86","author":"M Yoshida","year":"2010","unstructured":"Yoshida M (2010) Molecular approach to human leukemia: isolation and characterization of the first human retrovirus HTLV-1 and its impact on tumorigenesis in adult T-cell leukemia. Proc Jpn Acad Ser B Phys Biol Sci 86:117\u2013130","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"185_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fmicb.2013.00271","volume":"4","author":"MG Romanelli","year":"2013","unstructured":"Romanelli MG, Diani E, Bergamo E, Casoli C, Ciminale V, Bex F et al (2013) Highlights on distinctive structural and functional properties of HTLV Tax proteins. Front Microbiol 4:271","journal-title":"Front Microbiol"},{"key":"185_CR22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.coviro.2013.08.010","volume":"3","author":"M Matsuoka","year":"2013","unstructured":"Matsuoka M, Yasunaga J (2013) Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor. Curr Opin Virol 3:684\u2013691","journal-title":"Curr Opin Virol"},{"key":"185_CR23","first-page":"341","volume":"73","author":"Y Hinuma","year":"1982","unstructured":"Hinuma Y, Gotoh Y, Sugamura K, Nagata K, Goto T, Nakai M et al (1982) A retrovirus associated with human adult T-cell leukemia: in vitro activation. Gan 73:341\u2013344","journal-title":"Gan"},{"key":"185_CR24","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1073\/pnas.79.15.4780","volume":"79","author":"YI Gotoh","year":"1982","unstructured":"Gotoh YI, Sugamura K, Hinuma Y (1982) Healthy carriers of a human retrovirus, adult T-cell leukemia virus (ATLV): demonstration by clonal culture of ATLV-carrying T cells from peripheral blood. Proc Natl Acad Sci USA 79:4780\u20134782","journal-title":"Proc Natl Acad Sci USA"},{"key":"185_CR25","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/eji.200939451","volume":"39","author":"CR Bangham","year":"2009","unstructured":"Bangham CR (2009) CTL quality and the control of human retroviral infections. Eur J Immunol 39:1700\u20131712","journal-title":"Eur J Immunol"},{"key":"185_CR26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/aid.2013.0214","volume":"30","author":"Y Tanaka","year":"2014","unstructured":"Tanaka Y, Takahashi Y, Tanaka R, Kodama A, Fujii H, Hasegawa A et al (2014) Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46. AIDS Res Hum Retroviruses 30:542\u2013552","journal-title":"AIDS Res Hum Retroviruses"},{"key":"185_CR27","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.159.13.1485","volume":"159","author":"EL Murphy","year":"1999","unstructured":"Murphy EL, Glynn SA, Fridey J, Smith JW, Sacher RA, Nass CC et al (1999) Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study. Arch Intern Med 159:1485\u20131491","journal-title":"Arch Intern Med"},{"key":"185_CR28","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1378\/chest.124.6.2283","volume":"124","author":"Y Yamazato","year":"2003","unstructured":"Yamazato Y, Miyazato A, Kawakami K, Yara S, Kaneshima H, Saito A (2003) High expression of p40(tax) and pro-inflammatory cytokines and chemokines in the lungs of human T-lymphotropic virus type 1-related bronchopulmonary disorders. Chest 124:2283\u20132292","journal-title":"Chest"},{"key":"185_CR29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","volume":"4","author":"SB Santos","year":"2004","unstructured":"Santos SB, Porto AF, Muniz AL, de Jesus AR, Magalhaes E, Melo A et al (2004) Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 4:7","journal-title":"BMC Infect Dis"},{"key":"185_CR30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/clin.1996.0131","volume":"80","author":"N Funai","year":"1996","unstructured":"Funai N, Shimamoto Y, Yoshida S, Nagai Y, Nakazato S, Kohashi O (1996) Differences in immune functions between human T-lymphotropic virus type I carriers and patients with adult T-cell leukemia\/lymphoma. Clin Immunol Immunopathol 80:325\u2013332","journal-title":"Clin Immunol Immunopathol"},{"key":"185_CR31","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood.V97.10.3177","volume":"97","author":"J Yasunaga","year":"2001","unstructured":"Yasunaga J, Sakai T, Nosaka K, Etoh K, Tamiya S, Koga S et al (2001) Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 97:3177\u20133183","journal-title":"Blood"},{"key":"185_CR32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2010-03-272690","volume":"117","author":"CR Nascimento","year":"2011","unstructured":"Nascimento CR, Lima MA, de Andrada Serpa MJ, Espindola O, Leite AC, Echevarria-Lima J (2011) Monocytes from HTLV-1-infected patients are unable to fully mature into dendritic cells. Blood 117:489\u2013499","journal-title":"Blood"},{"key":"185_CR33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0145-2126(03)00255-8","volume":"28","author":"BD Hock","year":"2004","unstructured":"Hock BD, Haring LF, Steinkasserer A, Taylor KG, Patton WN, McKenzie JL (2004) The soluble form of CD83 is present at elevated levels in a number of hematological malignancies. Leuk Res 28:237\u2013241","journal-title":"Leuk Res"},{"key":"185_CR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1349-7006.1996.tb00210.x","volume":"87","author":"N Higashimura","year":"1996","unstructured":"Higashimura N, Takasawa N, Tanaka Y, Nakamura M, Sugamura K (1996) Induction of OX40, a receptor of gp34, on T cells by trans-acting transcriptional activator, Tax, of human T-cell leukemia virus type I. Jpn J Cancer Res 87:227\u2013231","journal-title":"Jpn J Cancer Res"},{"key":"185_CR35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/v3081439","volume":"3","author":"AK Kress","year":"2011","unstructured":"Kress AK, Grassmann R, Fleckenstein B (2011) Cell surface markers in HTLV-1 pathogenesis. Viruses 3:1439\u20131459","journal-title":"Viruses"},{"key":"185_CR36","doi-asserted-by":"crossref","first-page":"14119","DOI":"10.1074\/jbc.273.23.14119","volume":"273","author":"K Ohtani","year":"1998","unstructured":"Ohtani K, Tsujimoto A, Tsukahara T, Numata N, Miura S, Sugamura K et al (1998) Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I. J Biol Chem 273:14119\u201314129","journal-title":"J Biol Chem"},{"key":"185_CR37","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1128\/JVI.77.15.8290-8298.2003","volume":"77","author":"D Dudziak","year":"2003","unstructured":"Dudziak D, Kieser A, Dirmeier U, Nimmerjahn F, Berchtold S, Steinkasserer A et al (2003) Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway. J Virol 77:8290\u20138298","journal-title":"J Virol"},{"key":"185_CR38","first-page":"2360","volume":"93","author":"N Mori","year":"1999","unstructured":"Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW et al (1999) Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 93:2360\u20132368","journal-title":"Blood"},{"key":"185_CR39","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1182\/blood-2003-12-4350","volume":"103","author":"B Senechal","year":"2004","unstructured":"Senechal B, Boruchov AM, Reagan JL, Hart DN, Young JW (2004) Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103:4207\u20134215","journal-title":"Blood"},{"key":"185_CR40","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1128\/JVI.02327-06","volume":"81","author":"M Kummer","year":"2007","unstructured":"Kummer M, Turza NM, Muhl-Zurbes P, Lechmann M, Boutell C, Coffin RS et al (2007) Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome. J Virol 81:6326\u20136338","journal-title":"J Virol"},{"key":"185_CR41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/mi.2014.79","volume":"8","author":"JM Bates","year":"2015","unstructured":"Bates JM, Flanagan K, Mo L, Ota N, Ding J, Ho S et al (2015) Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis. Mucosal Immunol 8:414\u2013428","journal-title":"Mucosal Immunol"},{"key":"185_CR42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/JVI.75.1.192-198.2001","volume":"75","author":"M Moriuchi","year":"2001","unstructured":"Moriuchi M, Inoue H, Moriuchi H (2001) Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J Virol 75:192\u2013198","journal-title":"J Virol"},{"key":"185_CR43","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1128\/JVI.77.20.11170-11179.2003","volume":"77","author":"N Dumais","year":"2003","unstructured":"Dumais N, Pare ME, Mercier S, Bounou S, Marriot SJ, Barbeau B et al (2003) T-cell receptor\/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1. J Virol 77:11170\u201311179","journal-title":"J Virol"},{"key":"185_CR44","doi-asserted-by":"crossref","first-page":"e1003271","DOI":"10.1371\/journal.ppat.1003271","volume":"9","author":"A Melamed","year":"2013","unstructured":"Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CR (2013) Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog 9:e1003271","journal-title":"PLoS Pathog"},{"key":"185_CR45","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.4049\/jimmunol.144.11.4202","volume":"144","author":"Y Tanaka","year":"1990","unstructured":"Tanaka Y, Tozawa H, Koyanagi Y, Shida H (1990) Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells. J Immunol 144:4202\u20134211","journal-title":"J Immunol"},{"key":"185_CR46","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1128\/MCB.11.3.1313","volume":"11","author":"S Miura","year":"1991","unstructured":"Miura S, Ohtani K, Numata N, Niki M, Ohbo K, Ina Y et al (1991) Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol Cell Biol 11:1313\u20131325","journal-title":"Mol Cell Biol"},{"key":"185_CR47","first-page":"1132","volume":"76","author":"Y Ootsuyama","year":"1985","unstructured":"Ootsuyama Y, Shimotohno K, Miwa M, Oroszlan S, Sugimura T (1985) Myristylation of gag protein in human T-cell leukemia virus type-I and type-II. Jpn J Cancer Res 76:1132\u20131135","journal-title":"Jpn J Cancer Res"},{"key":"185_CR48","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1128\/JVI.75.23.11534-11543.2001","volume":"75","author":"R Tanaka","year":"2001","unstructured":"Tanaka R, Yoshida A, Murakami T, Baba E, Lichtenfeld J, Omori T et al (2001) Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection. J Virol 75:11534\u201311543","journal-title":"J Virol"},{"key":"185_CR49","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1073\/pnas.84.14.4831","volume":"84","author":"P Gunning","year":"1987","unstructured":"Gunning P, Leavitt J, Muscat G, Ng SY, Kedes L (1987) A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 84:4831\u20134835","journal-title":"Proc Natl Acad Sci USA"},{"key":"185_CR50","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1128\/JVI.71.6.4445-4451.1997","volume":"71","author":"K Matsumoto","year":"1997","unstructured":"Matsumoto K, Shibata H, Fujisawa JI, Inoue H, Hakura A, Tsukahara T et al (1997) Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J Virol 71:4445\u20134451","journal-title":"J Virol"},{"key":"185_CR51","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/sj.onc.1201045","volume":"14","author":"T Akagi","year":"1997","unstructured":"Akagi T, Ono H, Nyunoya H, Shimotohno K (1997) Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes. Oncogene 14:2071\u20132078","journal-title":"Oncogene"},{"key":"185_CR52","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1073\/pnas.91.9.3584","volume":"91","author":"H Hirai","year":"1994","unstructured":"Hirai H, Suzuki T, Fujisawa J, Inoue J, Yoshida M (1994) Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation. Proc Natl Acad Sci USA 91:3584\u20133588","journal-title":"Proc Natl Acad Sci USA"},{"key":"185_CR53","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/JVI.63.8.3234-3239.1989","volume":"63","author":"J Fujisawa","year":"1989","unstructured":"Fujisawa J, Toita M, Yoshida M (1989) A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements. J Virol 63:3234\u20133239","journal-title":"J Virol"},{"key":"185_CR54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V81.2.454.454","volume":"81","author":"EJ Kozlow","year":"1993","unstructured":"Kozlow EJ, Wilson GL, Fox CH, Kehrl JH (1993) Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood 81:454\u2013461","journal-title":"Blood"},{"key":"185_CR55","doi-asserted-by":"crossref","first-page":"25501","DOI":"10.1074\/jbc.M109.010959","volume":"284","author":"M Mizuguchi","year":"2009","unstructured":"Mizuguchi M, Asao H, Hara T, Higuchi M, Fujii M, Nakamura M (2009) Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells. J Biol Chem 284:25501\u201325511","journal-title":"J Biol Chem"},{"key":"185_CR56","first-page":"1737","volume":"7","author":"H Hirai","year":"1992","unstructured":"Hirai H, Fujisawa J, Suzuki T, Ueda K, Muramatsu M, Tsuboi A et al (1992) Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105. Oncogene 7:1737\u20131742","journal-title":"Oncogene"},{"key":"185_CR57","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1074\/jbc.275.15.11154","volume":"275","author":"K Ohtani","year":"2000","unstructured":"Ohtani K, Iwanaga R, Arai M, Huang Y, Matsumura Y, Nakamura M (2000) Cell type-specific E2F activation and cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. J Biol Chem 275:11154\u201311163","journal-title":"J Biol Chem"},{"key":"185_CR58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/j.1460-2075.1987.tb04767.x","volume":"6","author":"K Ohtani","year":"1987","unstructured":"Ohtani K, Nakamura M, Saito S, Noda T, Ito Y, Sugamura K et al (1987) Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J 6:389\u2013395","journal-title":"EMBO J"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-015-0185-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T22:01:50Z","timestamp":1691791310000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.retrovirology.com\/content\/12\/1\/56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1186\/s12977-015-0185-1","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,1]]},"article-number":"56"}}